Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Redhill Rises Most in a Month as FDA Approves Drug Trial

Redhill Biopharma Ltd. surged the most in almost one month after the Israeli biopharmaceutical company said it received U.S. Food and Drug Administration approval for a clinical trial of its RHB-102 drug.

The shares jumped 2.8 percent, the most since Jan. 19, to 2.201 shekels at the 5 p.m. close in Tel Aviv, giving the company a market value of 113 million shekels ($30 million).

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.